Welcome to Therawis

Our mission is to combine highly innovative and novel diagnostics with effective therapeutics in oncology:

”The theranostic approach”

therascreen PITX2 RGQ PCR Kit (QIAGEN) is a novel clinically validated CE-IVD assay to determine the level of PITX2 methylation which helps predicting patient outcome to anthracycline-based chemotherapy and may help improve therapy decision-making.

Contact:

Therawis Pharma GmbH

Therawis Diagnostics GmbH

Grillparzerstrasse 14

81675 Munich Germany

Tel.: +49 (0) 89 41 42 45 57 0

Fax. +49 (0) 89 41 42 45 57 40

E-Mail: info@therawis.com

Website: http://www.therawis.com

 

Where to meet us:

< 2018 >
March
MTuWThFSS
   1234
567891011
12131415161718
192021
  • All day
    2018.03.21-2018.03.23

    XPOMET © Convention will be held from March 21 – 23, 2018 at the KONGRESSHALLE am Zoo Leipzig.

    Presenter: Prof. Wilhelm

22232425
262728293031 
© 2018 Therawis - All Rights Reserved